Novel Humanized Biosimulator to Predict Coronary Obstruction in High-Risk Valve-in-Valve Procedures.

Authors :: Perrin N
Bonnet G
Ibrahim R
Bonan R
Leroux L
Granada JF
Tardif JC
Modine T
Ben Ali W
Source :: JACC. Case reports [JACC Case Rep] 2022 Dec 24; Vol. 7, pp. 101711. Date of Electronic Publication: 2022 Dec 24 (Print Publication: 2023).
Publication Year :: 2022
Abstract: We developed humanized biosimulator to predict the risk of coronary obstruction among high-risk patients undergoing valve-in-valve (ViV) procedures. In this case, based on unchanged instantaneous wave-free ratio values measured during a ViV simulation session, the procedure was performed safely in the patient the day afterward, without coronary artery issues and with good hemodynamic results. ( Level of Difficulty: Advanced. ).<br />Competing Interests: The authors have reported that they have no relationships relevant to the contents of this paper to disclose.<br /> (© 2023 The Authors.)

Full Text Access

Tools